SelectQuote(SLQT)

Search documents
SelectQuote(SLQT) - 2022 Q3 - Earnings Call Presentation
2022-05-16 02:44
| --- | --- | --- | --- | --- | |-------|---------------------------------------------------|-------|-------|-------| | | Quarter Fiscal 2022 | | | | | | Earnings Conference Call Presentation May 5, 2022 | | | | | We shop. You save. Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, m ...
SelectQuote(SLQT) - 2022 Q3 - Earnings Call Transcript
2022-05-07 16:12
SelectQuote, Inc. (NYSE:SLQT) Q3 2022 Earnings Conference Call May 5, 2022 8:30 AM ET Company Participants Matt Gunter - Investor Relations Tim Danker - Chief Executive Officer Raff Sadun - Chief Financial Officer Bill Grant - Chief Operating Officer Conference Call Participants Daniel Grosslight - Citi Jeff Garro - Piper Sandler Jonathan Yong - Credit Suisse Thomas McJoynt-Griffith - KBW Operator Welcome to the SelectQuote's Third Quarter Earnings Conference Call. All lines have been placed on mute to pr ...
SelectQuote(SLQT) - 2022 Q3 - Quarterly Report
2022-05-05 11:37
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2022 (913) 599-9225 (Registrant's telephone number, including area code) (Former name, former address and former fiscal year, if changed since last report) OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ...
SelectQuote(SLQT) - 2022 Q2 - Quarterly Report
2022-02-14 14:03
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended December 31, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) SelectQuote, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3339273 (State or other j ...
SelectQuote(SLQT) - 2022 Q2 - Earnings Call Presentation
2022-02-08 09:48
2 nd Quarter Fiscal 2022 Earnings Conference Call Presentation February 7, 2022 | We shop. You save. Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," " ...
SelectQuote(SLQT) - 2022 Q2 - Earnings Call Transcript
2022-02-08 04:10
Financial Data and Key Metrics Changes - SelectQuote's consolidated revenue for Q2 2022 totaled $195 million, a decrease of 45% year-over-year, while adjusted EBITDA was negative $163 million [9][10][44] - The company recognized a cohort sale adjustment of $145 million, reflecting lower persistency primarily due to higher intra-year loss rates experienced in 2021 [9][10][45] - The new outlook for full-year revenue is projected to be between $810 million and $850 million, with adjusted EBITDA expected to be negative between $235 million and $260 million [10][71] Business Line Data and Key Metrics Changes - The total approved policies grew by 22%, and Medicare Advantage (MA) approved policies increased by 27%, although the growth was lower than submitted policy growth due to higher switching activity [51][52] - Agent productivity declined by 45%, with average close rates down more than 20% compared to the previous season, significantly impacting overall performance [52][54] Market Data and Key Metrics Changes - The Medicare Advantage market experienced increased shopping behavior among consumers, but this led to lower close rates due to greater parity in plan features across carriers [17][19][76] - The company noted that the competitive landscape has changed, with carriers focusing on specific benefits, which has created challenges in closing sales [88] Company Strategy and Development Direction - SelectQuote is actively reviewing its business strategy, particularly in the senior Medicare Advantage distribution business, aiming to reset growth philosophy to focus on repeatable unit operating margins and predictable cash flows [11][25][30] - The company plans to reduce the number of flex agents and hire core agents earlier to improve training and onboarding, thereby enhancing close rates and agent productivity [40][48] Management's Comments on Operating Environment and Future Outlook - Management described the quarter as disappointing and acknowledged the need for a strategic shift to mitigate volatility and improve profitability [7][10][47] - The company remains committed to leveraging its unique position in the healthcare landscape, particularly through its Population Health initiatives, which are expected to contribute to future growth [29][72] Other Important Information - SelectQuote's SelectRx pharmacy solution has seen strong consumer interest, with over 40,000 gross customer enrollments and 10,000 active members receiving prescriptions [12][64][67] - The company ended the quarter with $193 million in cash and $717 million in debt, indicating a significant cash outflow during the quarter due to operational expenses [68][70] Q&A Session Summary Question: Understanding the impact of plan parity on close rates - Management explained that the AEP was unique due to industry-wide CMS issues and a tight labor market, which masked underlying issues, with plan parity being a significant factor in lower close rates [76][77] Question: Long-term growth expectations - Management indicated that while they are not providing specific guidance for fiscal '23, they plan to reset the baseline for policy production and expect modest growth thereafter [79][81] Question: Correlation with competitors' results - Management acknowledged that while some issues may correlate with competitors like Humana, they believe their engagement with carriers remains strong and beneficial [86][87] Question: Cash flow breakeven timeline - Management stated that by pulling back on growth and resetting the baseline, they expect to see benefits in cash flow and aim for breakeven in the near future [91][93] Question: Customer acquisition and lead generation - Management noted that while lead costs have remained stable, the focus will be on optimizing lead channels and improving the quality of leads to enhance close rates [94][96]
SelectQuote(SLQT) - 2021 Q3 - Earnings Call Transcript
2021-11-07 16:06
SelectQuote, Inc. (NYSE:SLQT) Q3 2021 Earnings Conference Call November 4, 2021 5:00 PM ET Company Participants Matt Gunter - IR Tim Danker - CEO Raff Sadun - CFO Bob Grant - President, Senior Division Bill Grant - COO Conference Call Participants Jailendra Singh - Credit Suisse Elizabeth Anderson - Evercore Jeff Garro - Piper Sandler Daniel Grosslight - Citi Frank Morgan - RBC Capital Markets Meyer Shields - KBW Operator Good day, and thank you for standing by. Welcome to the SelectQuote fiscal first quart ...
SelectQuote(SLQT) - 2021 Q1 - Earnings Call Presentation
2021-11-07 09:39
1 st Quarter Fiscal 2022 | We shop. You save. 1 Earnings Conference Call Presentation November 4, 2021 Disclaimer Forward-Looking Statements This presentation contains forward-looking statements. These forward-looking statements reflect our current views with respect to, among other things, future events and our financial performance. These statements are often, but not always, made through the use of words or phrases such as "may," "should," "could," "predict," "potential," "believe," "will likely result," ...
SelectQuote(SLQT) - 2022 Q1 - Quarterly Report
2021-11-05 13:02
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) SelectQuote, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3339273 (State or other ...
SelectQuote(SLQT) - 2021 Q4 - Annual Report
2021-08-26 20:55
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the year ended June 30, 2021 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to 001-39295 (Commission File Number) SelectQuote, Inc. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organiz ...